Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 35
Filter
1.
Int J Oral Maxillofac Surg ; 49(2): 264-271, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31350123

ABSTRACT

This study was performed to address the outcomes of patients treated with onlay grafts from the iliac crest to augment the deficient jaw. The results of 173 consecutive patients who underwent bone grafting prior to implant surgery are presented. The grafts were taken from the anterior iliac crest to repair alveolar bone deficiencies that were too large to be corrected using intraoral bone grafts. Three months postoperatively, 869 implants were placed into 190 onlay grafts (167 grafts in the maxilla, 23 in the mandible). The follow-up ranged from 3 months to 23 years post implantation. All patients received a fixed prosthesis. Parameters examined included healing of the donor site and bone grafts, implant survival, peri-implant condition, and donor site morbidity. The overall survival rate for all implants was calculated to be 95%±2.7% according to Kaplan-Meier analysis. The implant survival rate compares favourably with those reported in studies using intraoral and extraoral bone.


Subject(s)
Alveolar Ridge Augmentation , Dental Implants , Bone Transplantation , Dental Implantation, Endosseous , Follow-Up Studies , Humans , Ilium , Mandible , Maxilla , Retrospective Studies
2.
Anaesthesia ; 74(5): 638-650, 2019 May.
Article in English | MEDLINE | ID: mdl-30714123

ABSTRACT

There has been an increase in the number of units providing anaesthesia for magnetic resonance imaging and the strength of magnetic resonance scanners, as well as the number of interventions and operations performed within the magnetic resonance environment. More devices and implants are now magnetic resonance imaging conditional, allowing scans to be undertaken in patients for whom this was previously not possible. There has also been a revision in terminology relating to magnetic resonance safety of devices. These guidelines have been put together by organisations who are involved in the pathways for patients needing magnetic resonance imaging. They reinforce the safety aspects of providing anaesthesia in the magnetic resonance environment, from the multidisciplinary decision making process, the seniority of anaesthetist accompanying the patient, to training in the recognition of hazards of anaesthesia in the magnetic resonance environment. For many anaesthetists this is an unfamiliar site to give anaesthesia, often in a remote site. Hospitals should develop and audit governance procedures to ensure that anaesthetists of all grades are competent to deliver anaesthesia safely in this area.


Subject(s)
Anesthesia/methods , Magnetic Resonance Imaging/methods , Anesthesia/adverse effects , Anesthesia/standards , Anesthesiology/instrumentation , Clinical Competence , Contraindications, Procedure , Humans , Magnetic Resonance Imaging/adverse effects , Magnetic Resonance Imaging/instrumentation , Magnetic Resonance Imaging/standards , Noise/adverse effects , Occupational Health , Patient Safety , Prostheses and Implants , United Kingdom
3.
Res Integr Peer Rev ; 2: 15, 2017.
Article in English | MEDLINE | ID: mdl-29451565

ABSTRACT

BACKGROUND: Accurate reporting on sex and gender in health research is integral to ensuring that health interventions are safe and effective. In Canada and internationally, governments, research organizations, journal editors, and health agencies have called for more inclusive research, provision of sex-disaggregated data, and the integration of sex and gender analysis throughout the research process. Sex and gender analysis is generally defined as an approach for considering how and why different subpopulations (e.g., of diverse genders, ages, and social locations) may experience health conditions and interventions in different or similar ways.The objective of this study was to assess the extent and nature of reporting about sex and/or gender, including whether sex and gender analysis (SGA) was carried out in a sample of Canadian randomized controlled trials (RCTs) with human participants. METHODS: We searched MEDLINE from 01 January 2013 to 23 July 2014 using a validated filter for identification of RCTs, combined with terms related to Canada. Two reviewers screened the search results to identify the first 100 RCTs that were either identified in the trial publication as funded by a Canadian organization or which had a first or last author based in Canada. Data were independently extracted by two people from 10% of the RCTs during an initial training period; once agreement was reached on this sample, the remainder of the data extraction was completed by one person and verified by a second. RESULTS: The search yielded 1433 records. We screened 256 records to identify 100 RCTs which met our eligibility criteria. The median sample size of the RCTs was 107 participants (range 12-6085). While 98% of studies described the demographic composition of their participants by sex, only 6% conducted a subgroup analysis across sex and 4% reported sex-disaggregated data. No article defined "sex" and/or "gender." No publication carried out a comprehensive sex and gender analysis. CONCLUSIONS: Findings highlight poor uptake of sex and gender considerations in the Canadian RCT context and underscore the need for better articulated guidance on sex and gender analysis to improve reporting of evidence, inform policy development, and guide future research.

4.
Article in English | MEDLINE | ID: mdl-16021913

ABSTRACT

Adenosine (Ado) triggers several protective mechanisms that may attenuate development of heart failure, both locally and systemically. We developed a procedure allowing sustained increase in endogenous Ado production by the combined application of Ado metabolism inhibitors and nucleotide precursors. We found that our procedure attenuate the development of heart failure induced by adriamycin.


Subject(s)
Adenosine/metabolism , Antibiotics, Antineoplastic/adverse effects , Doxorubicin/adverse effects , Heart Failure/chemically induced , Animals , Chromatography, High Pressure Liquid , Doxorubicin/pharmacology , Echocardiography , Heart Failure/prevention & control , Nucleotides/chemistry , Rats , Rats, Sprague-Dawley , Time Factors
5.
Cardiovasc Surg ; 11(4): 299-303, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12802266

ABSTRACT

BACKGROUND: The Off-Pump Coronary Artery Bypass (OPCAB) technique is becoming more popular in many cardiac units throughout the world. This relatively new technique has prompted surgeons and anaesthetists to review and modify the routine approach to Coronary Artery Bypass Surgery (CABG). In this study we reviewed and analysed the outcome of an integrated anaesthetic and surgical peri-operative approach that allowed routine use of OPCAB and avoided the use of cardiopulmonary bypass (CPB). METHODS: We reviewed and analysed the data on the first consecutive 285 patients who were operated on using the OPCAB technique. These represent our initial experience with applying the OPCAB technique non-selectively for all patients over a period of 16 months. RESULTS: All patients had at least 2-vessel disease. 807 grafts were performed (mean 2.8 per patient) of which 647 (80%) were arterial (mean 2.3 per patient). 179 (63%) patients underwent total arterial revascularization. Eight patients required cardiopulmonary bypass; all other operations were completed off-pump. Complications--mortality 3 (1%); renal failure 24 (8%); stroke 3 (1%) and atrial fibrillation 60 (21%). CONCLUSION: This retrospective analysis shows that provided a combined and integrated anaesthetic and surgical approach is used, beating heart technique for CABG can be safely offered to all patients with a good outcome.


Subject(s)
Coronary Artery Bypass/methods , Blood Pressure/physiology , Coronary Disease/physiopathology , Coronary Disease/surgery , Female , Humans , Male , Middle Aged , Postoperative Complications/etiology , Retrospective Studies
7.
Int J Biochem Cell Biol ; 32(1): 41-62, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10661893

ABSTRACT

Since endothelins were discovered by Yanasigawa in 1988 it has been recognised that they may have an important role in lung pathophysiology. Despite their biological importance as vasoconstrictors the physiological role of endothelin has not yet been defined within the lungs. This review explores their role in acute and chronic disease. During acute inflammation and ischaemia-reperfusion injury cytokines may induce release of endothelin. This is important in the realm of acute lung injury and during surgical procedures such as cardiopulmonary operations including lung resections and transplantation. Complications of surgery including primary organ failure resulting in poor gas exchange as well as increased pulmonary vascular resistance have been linked to the presence of excessive endothelin. Endothelin may have an important role in transplantation biology. The complex process leading to successful lung transplantation includes optimising the donor with brain death, harvesting the lungs, managing acute and chronic rejection, and protecting the vital organs from toxic effects of immunosuppressants. During chronic disease processes, the mitotic action of endothelin may be important in vascular and airway remodelling by means of smooth muscle cell proliferation. We also explore recent advances in drug development, animal models and future directions for research.


Subject(s)
Endothelins/metabolism , Lung/physiopathology , Animals , Cardiovascular Diseases/physiopathology , Cardiovascular Diseases/surgery , Endothelin Receptor Antagonists , Endothelins/pharmacology , Humans , Lung/surgery , Lung Diseases/physiopathology , Lung Transplantation/immunology , Receptors, Endothelin/metabolism , Vasoconstrictor Agents/pharmacology
8.
Int J Clin Pract ; 53(4): 281-6, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10563073

ABSTRACT

Cardiac disease is known to increase the risk of non-cardiac surgery to patients who suffer from it. Clinical and investigation data may be used to identify those at increased risk. Attempts have been made to integrate these risk factors into systems that can quantify risk in terms of increased morbidity and mortality. In this article we discuss the various aspects of cardiac illness that are known to increase risk for patients and then look at the different scoring systems that have been produced. We consider the type and urgency of surgery and finish by providing an approach to risk assessment for non-cardiac surgery.


Subject(s)
Anesthesia/methods , Heart Diseases/complications , Surgical Procedures, Operative , Contraindications , Female , Humans , Male , Risk Assessment , Risk Factors
10.
Int J Clin Pract ; 53(5): 353-8, 1999.
Article in English | MEDLINE | ID: mdl-10695099

ABSTRACT

In an earlier article in this journal (June 1999) we discussed the risk that the presence of cardiac disease poses to patients undergoing non-cardiac surgery. We outlined factors in the patient's medical history, examination findings and the value of various tests in arriving at an overall assessment of risk for any given patient. In this article we concentrate on the management of these patients as they undergo surgery itself. We shall consider what measures may usefully be employed in order to minimise the risk of an adverse cardiac event occurring in the perioperative period.


Subject(s)
Intraoperative Complications/prevention & control , Myocardial Infarction/prevention & control , Adrenergic beta-Antagonists/therapeutic use , Catheterization, Swan-Ganz , Echocardiography, Transesophageal , Humans , Incidence , Intraoperative Care , Intraoperative Complications/etiology , Intraoperative Complications/mortality , Myocardial Infarction/etiology , Myocardial Infarction/mortality , Myocardial Ischemia/complications , Myocardial Ischemia/diagnostic imaging , Postoperative Care , Preoperative Care/methods , Risk Management
11.
Eur J Anaesthesiol ; 14(4): 428-31, 1997 Jul.
Article in English | MEDLINE | ID: mdl-9253572

ABSTRACT

The incidence of bacterial colonization of central venous catheters using a standard polyurethane catheter was compared with that using an antiseptic (silver sulphadiazine and chlorhexidine) impregnated catheter in a group of patients with thoracic organ transplantation. Colonization was reduced from 25 of 35 standard catheters to 10 of 44 study catheters (P < 0.002), a 68% reduction. Similarly, the incidence of concomitant infection, by the same organism at another site was reduced from 10 of 35 standard catheters to 4 of 44 study catheters (P < 0.03), a 63% reduction.


Subject(s)
Bacterial Infections/prevention & control , Catheterization, Central Venous/instrumentation , Disinfectants/pharmacology , Disinfection , Immunosuppression Therapy , Organ Transplantation , Adult , Bacterial Infections/microbiology , Chlorhexidine/pharmacology , Female , Humans , Male , Middle Aged , Silver Sulfadiazine/pharmacology
13.
Br J Clin Pract ; 51(1): 53-5, 1997.
Article in English | MEDLINE | ID: mdl-9158275

ABSTRACT

A 55-year-old man developed postoperative hypotension following orthotopic cardiac transplantation, unresponsive to support with inotropes and counterpulsation. Acute right ventricular failure was confirmed by transoesophageal echocardiography, and the introduction of inhaled nitric oxide resulted in immediate improvement. A beneficial effect persisted for 11 days, with hospital discharge two months postoperatively.


Subject(s)
Heart Transplantation , Nitric Oxide/administration & dosage , Postoperative Complications/drug therapy , Ventricular Dysfunction, Right/drug therapy , Administration, Inhalation , Hemodynamics , Humans , Male , Middle Aged , Treatment Outcome
15.
Br J Anaesth ; 75(6): 794-7, 1995 Dec.
Article in English | MEDLINE | ID: mdl-8672336

ABSTRACT

We describe the insertion of a permanent implantable left ventricular assist device and intraoperative transoesophageal echocardiography in this instance. We also review the literature on the use of intraoperative transoesophageal echocardiography.


Subject(s)
Cardiomyopathy, Dilated/surgery , Echocardiography, Transesophageal , Heart-Assist Devices , Monitoring, Intraoperative/methods , Adult , Humans , Male
18.
J Clin Lab Immunol ; 24(2): 51-6, 1987 Oct.
Article in English | MEDLINE | ID: mdl-3437439

ABSTRACT

The purpose of our study was to set up a reliable method for the measurement of complement activation by adapting the method of crossed immunoelectrophoresis. We utilised anti C3 antiserum and barbitone buffer, containing sufficient EDTA to prevent in vitro activation of complement. We studied 44 patients undergoing open heart surgery, with cardiopulmonary bypass (CPB) by the analysis of plasma samples taken during the operation, and also samples of plasma and dialysate effluent from patients with end stage renal failure undergoing continuous ambulatory peritoneal dialysis (CAPD). Measurements were also carried out on stored blood, aged serum and serum treated with varying doses of lipopolysaccharide (LPS). Complement activation occurs in 95% of patients during CPB with levels ranging from less than 4.5% to 11.3% of total C3, but there was no detectable activation in any pre-bypass sample. Negligible complement activation occurs in the plasma of CAPD patients, but the dialysate effluent gave results from undetectable levels to 31.7%, in the absence of clinical peritonitis. Variable in vitro complement activation occurs in aged serum, but it was not detectable in stored blood. Serum treated with LPS showed levels of activation directly proportional to the dose of LPS and measurable at a level of 0.1 microgram/ml of serum. The method had a coefficient of variation of 4.5%, and provides a reliable way of measuring complement activation in clinical situations such as cardiopulmonary bypass and peritoneal dialysis.


Subject(s)
Complement Activation , Immunoelectrophoresis, Two-Dimensional , Immunoelectrophoresis , Cardiopulmonary Bypass , Complement C3/analysis , Complement C3b/analysis , Complement C3c , Humans , Peritoneal Dialysis, Continuous Ambulatory
20.
Eur J Anaesthesiol ; 1(3): 253-67, 1984 Sep.
Article in English | MEDLINE | ID: mdl-6536515

ABSTRACT

Diazepam in propylene glycol (Valium, Roche) and midazolam (Hypnovel, Roche) were compared as sedatives in 40 patients undergoing minor oral surgery. Twenty patients received each drug. The cardiovascular effects, the acceptability of the drugs to patients and dentists and the incidence of anterograde amnesia and adverse venous sequelae were investigated. Serum benzodiazepine levels were measured and recovery studied by six psychomotor tests repeated over five hours. Both drugs provided safe and acceptable sedation. More amnesia was reported in the midazolam group and more adverse venous sequelae by the diazepam patients. The recovery tests showed that the time taken to return to pre-sedation scores varied with the tests used and there was no significant evidence of the midazolam group recovering more quickly. In particular, significant impairment of delayed memory recall persisted in both groups throughout the investigation period.


Subject(s)
Benzodiazepines , Diazepam , Hypnotics and Sedatives , Surgery, Oral , Adolescent , Adult , Benzodiazepines/adverse effects , Benzodiazepines/blood , Benzodiazepines/pharmacology , Diazepam/adverse effects , Diazepam/blood , Diazepam/pharmacology , Female , Hemodynamics/drug effects , Humans , Hypnotics and Sedatives/adverse effects , Hypnotics and Sedatives/blood , Hypnotics and Sedatives/pharmacology , Male , Memory/drug effects , Midazolam , Middle Aged , Motor Activity/drug effects , Psychological Tests , Reaction Time/drug effects , Time Factors , Veins/injuries
SELECTION OF CITATIONS
SEARCH DETAIL
...